Literature DB >> 23335345

Factors associated with attrition in a longitudinal rheumatoid arthritis registry.

Christine K Iannaccone1, Anne Fossel, Hsun Tsao, Jing Cui, Michael Weinblatt, Nancy Shadick.   

Abstract

OBJECTIVE: Loss of participants in longitudinal data collection can affect the validity of outcomes in rheumatoid arthritis (RA) registries. Prior research indicates that demographics and socioeconomic and psychosocial factors contribute to attrition. This study analyzed the characteristics of an RA registry that may contribute to attrition in a hospital-based population.
METHODS: Subjects consisted of RA patients enrolled in the Brigham and Women's Rheumatoid Arthritis Sequential Study. Demographics and clinical and psychological factors were evaluated in univariate analyses to determine differences between participants who dropped out and those who completed 5 years of followup. Univariate factors with a P value <0.1 were used in a survival analysis to determine significant factors associated with attrition. A secondary analysis looked at patients who dropped out during the first year.
RESULTS: A total of 1,144 RA participants were enrolled (509 completed 5 years of followup, 227 were still actively enrolled, and 408 dropped out). The attrition rate was 4.31% per 6-month cycle. Shorter disease duration, higher disease activity (3-variable Disease Activity Score in 28 joints using the C-reactive protein level), less education, RA drug therapy, and lower arthritis self-efficacy were statistically significant in multivariate survival analyses. In a secondary analysis, sex and age were the only additional factors found that contributed to attrition.
CONCLUSION: The attrition rate for this registry was similar to rates reported by other registries. Shorter disease duration, higher disease activity, and several other socioeconomic factors were associated. Men and younger patients tended to drop out during the first year. Population differences in each registry may result in different attrition patterns and ultimately, each longitudinal registry should consider conducting its own analyses.
Copyright © 2013 by the American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23335345     DOI: 10.1002/acr.21940

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  11 in total

1.  The longitudinal effect of biologic use on patient outcomes (disease activity, function, and disease severity) within a rheumatoid arthritis registry.

Authors:  Nancy A Shadick; Nicole M Gerlanc; Michelle L Frits; Bradley S Stolshek; Brenna L Brady; Christine Iannaccone; David Collier; Jing Cui; Alex Mutebi; Michael E Weinblatt
Journal:  Clin Rheumatol       Date:  2019-07-29       Impact factor: 2.980

2.  Are extra-spinal symptoms associated with quality of life in patients with axial spondyloarthritis? A 1-year follow-up study.

Authors:  Yu Heng Kwan; Warren Fong; Ying Ying Leung; Nai Lee Lui; Chuen Seng Tan; Rahul Malhotra; Truls Østbye; Julian Thumboo
Journal:  Clin Rheumatol       Date:  2019-03-23       Impact factor: 2.980

Review 3.  Spontaneous, drug-induced, and drug-free remission in peripheral and axial spondyloarthritis.

Authors:  Denis Poddubnyy; Lianne S Gensler
Journal:  Best Pract Res Clin Rheumatol       Date:  2014-11-10       Impact factor: 4.098

4.  Associations of smoking and alcohol consumption with disease activity and functional status in rheumatoid arthritis.

Authors:  Bing Lu; Young Hee Rho; Jing Cui; Christine K Iannaccone; Michelle L Frits; Elizabeth W Karlson; Nancy A Shadick
Journal:  J Rheumatol       Date:  2013-12-01       Impact factor: 4.666

5.  Association of Low Bone Mineral Density with Anti-Citrullinated Protein Antibody Positivity and Disease Activity in Established Rheumatoid Arthritis: Findings from a US Observational Cohort.

Authors:  Harris A Ahmad; Evo Alemao; Zhenchao Guo; Christine K Iannaccone; Michelle L Frits; Michael Weinblatt; Nancy A Shadick
Journal:  Adv Ther       Date:  2018-01-25       Impact factor: 3.845

6.  Prevalence and predictors for sustained remission in rheumatoid arthritis.

Authors:  Yoon-Kyoung Sung; Kazuki Yoshida; Femke H M Prince; Michelle L Frits; Soo-Kyung Cho; Jung-Yoon Choe; Hye-Soon Lee; Jisoo Lee; Shin-Seok Lee; Dae-Hyun Yoo; Simon M Helfgott; Nancy A Shadick; Michael E Weinblatt; Daniel H Solomon; Sang-Cheol Bae
Journal:  PLoS One       Date:  2019-04-19       Impact factor: 3.240

7.  Accounting for missing data caused by drug cessation in observational comparative effectiveness research: a simulation study.

Authors:  Denis Mongin; Kim Lauper; Axel Finckh; Thomas Frisell; Delphine Sophie Courvoisier
Journal:  Ann Rheum Dis       Date:  2022-01-13       Impact factor: 19.103

8.  Effects of Achieving Target Measures in Rheumatoid Arthritis on Functional Status, Quality of Life, and Resource Utilization: Analysis of Clinical Practice Data.

Authors:  Evo Alemao; Seongjung Joo; Hugh Kawabata; Maiwenn J Al; Paul D Allison; Maureen P M H Rutten-van Mölken; Michelle L Frits; Christine K Iannaccone; Nancy A Shadick; Michael E Weinblatt
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-03       Impact factor: 4.794

9.  Where are they now? Retention strategies over 25 years in the Coronary Artery Risk Development in Young Adults (CARDIA) Study.

Authors:  Ellen Funkhouser; Jennifer Wammack; Cathy Roche; Jared Reis; Stephen Sidney; Pamela Schreiner
Journal:  Contemp Clin Trials Commun       Date:  2017-12-20

10.  Data-Driven Patient Clustering and Differential Clinical Outcomes in the Brigham and Women's Rheumatoid Arthritis Sequential Study Registry.

Authors:  Jeffrey R Curtis; Michael Weinblatt; Kenneth Saag; Vivian P Bykerk; Daniel E Furst; Stefano Fiore; Gregory St John; Toshio Kimura; Shen Zheng; Clifton O Bingham; Grace Wright; Martin Bergman; Kamala Nola; Christina Charles-Schoeman; Nancy Shadick
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-03-13       Impact factor: 4.794

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.